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Biological differences among metazoans and between cell types in a given organism arise in large
part due to differences in gene expression patterns. Gene-distal enhancers are key contributors
to these expression patterns, exhibiting both sequence diversity and cell type specificity. Studies
of long-range interactions indicate that enhancers are often important determinants of nuclear
organization, contributing to a general model for enhancer function that involves direct
enhancer-promoter contact. However, mechanisms for enhancer function are emerging that do
not fit solely within such a model, suggesting that enhancers as a class of DNA regulatory element
may be functionally and mechanistically diverse.Introduction
Genomic DNA acts as a carrier of information in two fundamental
ways. First, in transcribed genes, it specifies the sequences of
protein-coding mRNAs and functional RNAs, as well as informa-
tion encoded in RNA that affects its processing and stability.
Second, in regulatory sequences, it provides sites for transcrip-
tion factors to bind, establishing the appropriate levels and
expression patterns of those genes. A large proportion of the
regulatory information that is necessary for gene expression is
confined to the promoter region immediately upstream of tran-
scription start sites. In single-celled organisms, this information
can serve to specify absolute levels of transcription and in
many cases can mediate alternate responses (up- or downregu-
lation) to external stimuli. Metazoans present a challenge in this
regard. A single genome specifies manymorphologically distinct
cell types and also directs the ordered processes of develop-
ment and differentiation that lead to the varied structures present
in an adult multicellular organism. Sequencing of metazoan
genomes has not revealed a simple correlation between genome
size, as measured by the number of genes, and relative
complexity, as measured by the number of cells and cell types
and diversity of behavior. The 959–1031 cells of the nematode
Caenorhabditis elegans and the trillions of cells in a typical
human are both specified by 20,000–25,000 protein-coding
genes. Thus, morphological and developmental complexity is
not a function of increased numbers of genes but of alternative
mechanisms. For example, a higher proportion of vertebrate
genes are subject to alternative splicing, as compared to inverte-
brates (Kim et al., 2007a). Notably, however, complexity can be
generated by diversification of the patterns in which genes are
expressed, both spatially and temporally, within an organism.
Such diversification is enabled by a correspondingly more
complex set of regulatory information in the genomes of meta-
zoans. In particular, in metazoans transcriptional regulation isoften decoupled from the confines of the promoter-proximal
region and distributed among distal sequence elements, termed
enhancers, which can be located far from the transcription start
site. This distribution of regulatory sequences evades the
limitations that are inherent in systems in which transcription is
a function solely of the few hundred base pairs immediately
upstream of a gene promoter. Recent developments in geno-
mics, coupled with studies of covalent histone modifications,
structural features of genomic DNA, functional assays for
regulatory elements, methods to investigate nuclear organiza-
tion, and cross-species sequence comparisons, have revealed
enhancers, as a class of regulatory element, to be generally
and fundamentally important for the normal regulation of genes
and thus for the generation of the morphological and behavioral
diversity that characterizes multicellular organisms.
Finding Enhancers
Structure and Sequence
Enhancers were first characterized using transient reporter gene
assays in cultured cell lines. The activity associated with such
elements—first described for viral sequences (Banerji et al.,
1981; Moreau et al., 1981) and subsequently for sequences orig-
inating frommetazoan gene loci (Banerji et al., 1983; Gillies et al.,
1983) —is the activation of transcription regardless of the
element’s location or orientation relative to the promoter within
a plasmid construct. This flexibility is the defining hallmark of
enhancers and remains part of their functional definition. They
are commonly found within the introns of the genes that they
regulate (or, in fact, within the introns of neighboring genes)
and often at prodigious distances from the promoter. One
of the most extreme examples known is a limb bud enhancer
for the mouse Sonic hedgehog (Shh) gene, which is located
within the intron of another gene more than 1 Mb from the Shh
gene promoter (Lettice et al., 2003; Sagai et al., 2005).Cell 144, February 4, 2011 ª2011 Elsevier Inc. 327
This flexibility, however, impedes attempts to comprehen-
sively identify and catalog the full population of enhancers within
the genome or, indeed, the full complement of enhancers that
act upon a single selected gene. Whereas the promoter of
a gene can be located simply by sequencing the 50 end of its
mRNA, no similarly clear-cut criterion exists that can pinpoint
the location of an enhancer or the target gene for its activity.
Enhancer detection therefore relies on a number of imperfect
measures of chromatin structure and sequence functionality.
Enhancers are typically found to colocalize with disruptions in
chromatin structure revealed by hypersensitivity to digestion by
DNaseI. DNaseI hypersensitivity was first discovered at the
promoter region of the Drosophila hsp70 gene (Wu, 1980) and
is usually thought to result from short (100–300 bp) regions of
genomic DNA from which nucleosomes are excluded due to
the binding of transcription factors (Elgin, 1988; Gross and Gar-
rard, 1988), although DNA bending by transcription factors has
also been implicated (Stamatoyannopoulos et al., 1995; Leach
et al., 2001). Enhancers consist of clusters of cognate binding
sites for transcription factors that can both exclude nucleo-
somes and bend DNA and are therefore marked by such
nuclease hypersensitivity. For several decades, scans of gene
loci for putative enhancer elements involved the slow and labo-
rious indirect end-labeling assay, but recent advances have al-
lowed the mapping of nuclease hypersensitivity genome-wide
using microarrays or high-throughput sequencing (Crawford
et al., 2006).
Another criterion employed for predicting putative enhancer
sequences is noncoding sequence conservation. The full utility
of this approach has only been realized in the past decade,
when multiple fully sequenced genomes have been available
for comparison. The principle, however, is well established,
resting on the assumption that conservation of DNA sequence
across evolution in regions that do not encode proteins implies
regulatory function. Nonfunctional sequences, in contrast, will
accumulate mutations over evolutionary timescales and eventu-
ally diverge. High-level expression of the mammalian b-globin
genes in erythroid cells, for example, requires a set of sequence
elements termed the locus control region (LCR) that is distrib-
uted across a region of 20–30 kb located upstream of the gene
cluster (Bender et al., 2000; Moon and Ley, 1990; Grosveld
et al., 1987; Hardison et al., 1997). Each of these sequence
elements shows significant sequence conservation among all
mammalian genomes sequenced thus far. More generalized
studies have similarly indicated that evolutionary DNA sequence
conservation can predict enhancer activity (Visel et al., 2009b;
Noonan and McCallion, 2010).
On the other hand, several well-documented examples exist of
genes that are expressed in identical patterns in different species
but that require the activities of enhancers that look nothing alike.
Both Drosophila and sepsid flies, for example, express ortholo-
gous even-skipped genes with identical patterns in the devel-
oping embryo, and this expression pattern is governed by
multiple enhancers. Sequence comparisons, however, fail to
reveal any significant similarities between the DNA sequences
of these enhancers (Hare et al., 2008). Similarly, expression of
the Pax2 gene in the Drosophila melanogaster eye is regulated,
in part, by a cone-specific enhancer within which multiple328 Cell 144, February 4, 2011 ª2011 Elsevier Inc.transcription factors bind in a specific pattern that can be disrup-
ted by small deviations in sequence of, or spacing between,
binding sites. Surprisingly, however, the cone-specific Pax2
enhancers in other Drosophila species exhibit very little conser-
vation of sequence or binding site spacing even though they
function identically when transferred into D. melanogaster
(Swanson et al., 2010). A systematic evaluation of a 40 kb region
encompassing the zebrafish phox2b gene showed that a large
proportion of sequences with demonstrable regulatory activity
were not identified by measures of evolutionary sequence
constraint (McGaughey et al., 2008).
In fact, comparisons of genome-wide transcription factor
binding patterns across species indicate that a large proportion
of enhancers are species specific. In an analysis of mouse and
human hepatocytes, for example, 41%–89% of binding sites
for four transcription factors were found to be species specific
(Odom et al., 2007). A subsequent study examined genome-
wide binding of the liver-specific transcription factors CEBPA
and HNF4a in multiple species (Schmidt et al., 2010). Only
10%–22% of binding sites were shared between placental
mammals (human, mouse, or dog), and this number was even
lower in comparisons betweenplacentalmammals and a nonpla-
cental mammal (opossum) or chicken. Moreover, variation in
transcription factor binding patterns appears to have a predomi-
nantly genetic origin. In mouse hepatocytes harboring an intact
human chromosome 21, binding patterns of the transcription
factors HNF1a, HNF4a, and HNF6 are nearly identical to those
observed on chromosome 21 in human hepatocytes (Wilson
et al., 2008). Combinedwith other indications that a large propor-
tion of functional enhancers is not subject to evolutionary
constraint (ENCODE Project Consortium, 2007; McGaughey
et al., 2008), such findings indicate that enhancers can ‘‘turn
over’’ rapidly over evolutionary timescales, even when associ-
ated gene expression patterns are conserved.
Thus, conservation of regulatory function is not always re-
flected in conservation of DNA sequence. An approach to
enhancer prediction that relies on sequence conservation alone
will fail to identify a large proportion of enhancers.
Chromatin and Transcription Factor Signatures
Recently, genome-wide studies have suggested that enhancers
exhibit a characteristic chromatin ‘‘signature’’ (Figure 1A). This
signature consists of monomethylation of histone H3 lysine 4
(H3K4Me1) in the absence of significant trimethylation
(H3K4Me3) (ENCODE Project Consortium, 2007; Heintzman
et al., 2007; Koch et al., 2007). Notably, H3K4Me3 is associated
with active gene promoters, which in turn exhibit low levels
of H3K4Me1 at the transcription start site. In other studies,
however, a sharp divide between H3K4Me3 present at pro-
moters, but not enhancers, or H3K4Me1 present at enhancers,
but not transcription start sites, has not been as obvious (Barski
et al., 2007; Wang et al., 2008). The basis for the discrepancy is
not clear, although each study utilized different sources of chro-
matin (transformed cell lines versus primary T lymphocytes),
protocols for isolation of chromatin (formaldehyde crosslinking
and sonication versus micrococcoal digestion of native chro-
matin), and antibodies. It is nevertheless now possible to catalog
enhancers by identifying histone methylation signatures that are
not associated with other functional elements.
Figure 1. Chromatin Signatures at
Enhancers and Promoters
(A) A histone H3K4 methylation signature marks
many enhancers and promoters. Red circles
indicate methyl groups on histone H3K4. H3K4
monomethylation is enriched at enhancers and is
generally low at transcription start sites. By
contrast, H3K4 trimethylation is largely absent
from enhancers and appears to predominate at
active promoters.
(B) A more complicated picture of histone modifi-
cations at enhancers. At the left, nucleosomes
near a ‘‘poised’’ enhancer in a stem cell are
marked by H3K4 monomethylation, but also by
H3K27 trimethylation, so the enhancer is not
active. Upon differentiation, the H3K27 trimethyl
mark is lost, while enhancer-binding factors recruit
p300 or other histone acetyltransferases, resulting
in H3K27 acetylation (blue circles). This results in
enhancer activation and active transcription of
target genes.The H3K4 methylation signature has been correlated with
enhancer activity in gain-of-function assays (ENCODE Project
Consortium, 2007; Heintzman et al., 2007) but imperfectly. This
result is perhaps unsurprising because the transient reporter
gene assay is often a poor proxy for the activities of regulatory
elements integrated in the genome, which can be active in
narrow windows of development and/or cellular differentiation.
Enhancer predictions become more significant, however, when
the histone methylation signature is combined with other indica-
tors of enhancer activity in a specific cell type, such as transcrip-
tion cofactor binding—most often, the acetyltransferase p300
(Visel et al., 2009a; Blow et al., 2010; Ghisletti et al., 2010).
In addition, studies utilizing embryonic stem (ES) cells and
multiple primary cell types suggest that acetylation of histone
H3K27 in combination with H3K4Me1 is correlated with
enhancers near active genes, whereasH3K4Me1, in the absence
of H3K27 acetylation, appears to mark inactive or ‘‘poised’’
enhancers (Creyghton et al., 2010; Rada-Iglesias et al., 2010).
Notably, p300 can acetylate H3K27. Moreover, many poised
enhancers in ES cells were instead associated with H3K27Me3,
and at a subset of these enhancers, the H3K27Me3 mark was
replaced with H3K27Ac upon differentiation of ES cells along
a neuronal pathway (Figure 1B; Rada-Iglesias et al., 2010). The
available evidence suggests thatH3K4Me1 represents ageneral-
ized, although perhaps not all-inclusive, mark for distal
enhancers in a given cell type. Additional modifications can
then distinguish between enhancers that are active and those
that are potentiated for activity in response to growth conditions
or cell fate decisions.
Themost accurate predictions for enhancer activity to date are
derived from combinatorial analysis of the binding of multiple
transcription factors across the genome in Drosophila (Zinzen
et al., 2009). In this study, binding of five transcription factors
known to be involved in the differentiation of different muscle
cell types from mesoderm was mapped genome-wide at
different stages of development. A machine learning method
was then applied to this data set in order to derive predictions
for enhancers that are active in different cell types. Using this
approach, the authors were able to identify 77% of all previously
characterized muscle-specific enhancers in five different celltypes in Drosophila and had a roughly equivalent success rate
when predicted sequences were tested for enhancer activity.
If one accepts the description of a chromatin ‘‘signature’’ for
enhancers, current evidence then suggests that mammalian
genomes harbor an abundance of such elements and that they
are the major determinant of cell type specificity in gene expres-
sion. Examination of genome-wide H3K4 methylation patterns in
two cell lines—K562, a human erythroleukemia, and HeLa, a
human cervical carcinoma—resulted in an estimate of 24,000–
36,000 enhancers in each line (Heintzman et al., 2009). When
the locations of these enhancers were compared between the
two lines, only 5000 were found to be present in both. Analysis
of histone modification patterns across a region comprising
1% of the human genome, compared among five different cell
lines, revealed a frequency of H3K4Me1 distal from promoters
that agrees roughly with the genome-wide K562/HeLa study
and also indicated that a much higher number of enhancers
defined by this criterion exhibited cell type specificity, as
compared to promoters (Koch et al., 2007).
Genome-wide mapping of nuclease hypersensitive sites (HSs)
also suggests that enhancers are the primary determinant of cell
type specificity. A survey of HSs across 1% of the human
genome in six cell lines (including HeLa and K562) established
a strong correlation between hypersensitive sites that were cell
type specific and enhancer elements, as defined by the
H3K4Me signature (Xi et al., 2007).
Based on such observations, it has been suggested that the
human genome might harbor as many as 1 3 106 enhancers
(Heintzman et al., 2009). At present, however, this is little more
than the roughest of estimates because it is not clear how exten-
sive variability in the H3K4Me signature actually is in vivo. For
example, as yet, no studies have addressed the degree of over-
lap between cells within a specific lineage at different stages of
differentiation or similar cells at different stages of embryonic
development. There is also no a priori reason to expect that
enhancers as a general class of functional genomic element
should necessarily exhibit the same histone methylation pattern.
A study of human CD4+ T cells that investigated 39 distinct
chromatin-associated marks identified several different histone
modifications that correlated with putative enhancers, but noCell 144, February 4, 2011 ª2011 Elsevier Inc. 329
Figure 2. Enhancer Looping and Variant
Models
(A) Simplified schematic of how enhancers might
interact directly with promoters. Nucleosomes are
shown as yellow circles, and the default state for
chromatin is shown as a 30 nm fiber. Factors are
bound to both the enhancer (E, orange bar) and
promoter (P, blue bar). These factors can poten-
tially interact with each other, and when they do,
transcription is activated. The simplestmechanism
by which such interaction might be accomplished
is via free diffusion in thenucleus (horizontal arrow).
Enhancer-promoter interactions might be facili-
tatedby additional factors (blue circles) that bind to
the intervening sequences and organize them to
bring the enhancer and promoter into proximity
(vertical arrows). Alternatively, both enhancer and
promoter can interact with RNA polymerase II,
which then serves to bring the elements into
proximity via association with a common RNA
polymerase II transcription ‘‘factory’’ (diagonal
arrow).
(B) Tracking. The enhancer-bound complex (red
oval) actively scansalong thechromatin fiber until it
encounters the promoter complex (pink oval) and
activates transcription.single modification was completely predictive (Wang et al.,
2008). Finally, despite studies such as this, dozens of histone
modifications remain untested. Thus, a true enhancer census
remains a subject of speculation.
Mechanisms of Enhancer Function
Enhancer-Promoter Interactions
Since the discovery of enhancers, the dominant model for their
mechanism of action on promoters has invoked direct interac-
tions (Figure 2A). This model is commonly termed ‘‘looping,’’
as it requires that the intervening DNA be looped out or otherwise
organized in order to permit the enhancer-promoter interaction
(Bulger and Groudine, 1999; Blackwood and Kadonaga, 1998;
de Laat et al., 2008). Alternative models for enhancer function
have chiefly differed from the basic ‘‘looping’’ premise only in
how the enhancer-promoter interaction is established—whether
by free or facilitated diffusion within the nucleus or by an active
‘‘scanning’’ or ‘‘tracking’’ mechanism (Figure 2B) in which the
enhancer diffuses one-dimensionally along the chromatin fiber
in search of a promoter (Blackwood and Kadonaga, 1998). In
addition, more indirect models have been proposed, including
‘‘oozing’’ or ‘‘linking,’’ in which a complex is nucleated at the
enhancer and then polymerizes along the chromatin fiber bidi-
rectionally until it reaches a promoter (Ptashne, 1986; Dorsett,
1999; Bulger and Groudine, 1999). In one variation of this model,
RNA polymerase II or other complexes are loaded at the
enhancer and then actively move along the DNA until reaching
a promoter.
The ‘‘looping’’ model in particular has received abundant
support from studies of nuclear architecture utilizing ‘‘chromo-
some conformation capture’’ (3C) and its high-throughput deriv-
atives. In this assay, interactions between two genomic regions
are identified by crosslinking, restriction endonuclease diges-
tion, intermolecular ligation, and PCR analysis of the resulting
ligated products (Cullen et al., 1993; Dekker et al., 2002; Miele
and Dekker, 2009). Using this procedure, specific genomic330 Cell 144, February 4, 2011 ª2011 Elsevier Inc.restriction fragments located far from each other on the linear
genome can be found to interact with a greater frequency than
more proximal fragments if the sequences colocalize within the
three-dimensional space of the nucleus. This approach has
been adapted to produce genome-wide maps of the three-
dimensional associations that a specific locus makes among
all of the other sequences in the genome (‘‘4C’’) (Zhao et al.,
2006; Simonis et al., 2006) or even associations among multiple
sequences located throughout the genome (‘‘5C’’ and ‘‘Hi-C’’)
(Dostie et al., 2006; Lieberman-Aiden et al., 2009).
3C has been employed to reveal interactions between distal
sequence elements—primarily enhancers and promoters—
within multiple loci in mammalian genomes (Miele and Dekker,
2008; de Laat et al., 2008). It is now common to find distal
enhancers that colocalize with the promoters they regulate,
which has uniformly been interpreted to be the result of direct
enhancer-promoter interactions that are necessary for gene acti-
vation. Moreover, at multiple gene loci, strong correlations have
been made between active transcription and the ability to reveal
such associations. Within the mammalian b-globin locus, for
example, transcription factor knockouts that eliminate b-globin
gene transcription uniformly result in the loss of colocalization
of the gene with the b-globin LCR, as revealed by 3C (Drissen
et al., 2004; Vakoc et al., 2005).
Additional support for direct communication between
enhancers and promoters is provided by indications that
enhancer-promoter interactions can be specific. As a general
rule, enhancers are capable of activating transcription from
heterologous promoters, and in fact in the majority of gain-of-
function assays, reporter gene expression follows the pattern
governed by the enhancer, not the promoter. Some notable
exceptions to this principle have been demonstrated, however.
In the Drosophila Antennapedia gene complex, for example, an
enhancer specifically mediates activation of the Sex combs
reduced (Scr) gene despite the presence of another active
gene, fushi tarazu (ftz), located between it and the Scr promoter
(Calhoun et al., 2002; Calhoun and Levine, 2003). This interaction
requires a ‘‘tethering’’ element near the Scr promoter, which can
direct the enhancer to activate the ftz gene if it is moved to the ftz
promoter instead. A similar element within the promoter of the
Drosophila yellow gene renders heterologous promoters
capable of being activated by the otherwise highly specific
yellow gene enhancers (Melnikova et al., 2008). In addition,
several studies have indicated that some enhancers can exhibit
a preference for specific classes of gene promoters, for
example, between promoters that harbor a canonical TATA
box versus promoters that contain a DPE (Ohtsuki et al., 1998;
Butler and Kadonaga, 2001). Transcription of the ftz gene is
mediated by an enhancer bound by the transcription factor
Caudal, which specifically activates genes with DPE-containing
promoters (Juven-Gershon et al., 2008).
Nuclear Organization
Evidence supporting enhancer-promoter interactions is part of
a large and growing body of studies that have suggested that
nuclear architecture is a major determinant of gene expression.
Several generalized properties of genomic organization within
the nucleus have been established, and enhancers have been
shown to influence many of them.
First, each chromosome occupies a distinct ‘‘territory’’ within
the nucleus, although up to 20% of the volume of the nucleus
may be comprised of intermingling of neighboring chromosomes
(Cremer and Cremer, 2010; Branco and Pombo, 2007). In addi-
tion, specific sequences on a given chromosome have been
observed to extrude or ‘‘loop’’ out from the main body and can
even be found in other chromosomal territories (CTs). A study
of the b-globin locus, for example, found that the region extruded
from its CT specifically in erythroid cells (Ragoczy et al., 2003).
This extrusion or looping from the CT occurred prior to high-level
b-globin gene expression and was dependent upon the pres-
ence of the b-globin LCR. Furthermore, ectopic integration of
a b-globin LCR into a gene-dense region of the mouse genome
resulted in more frequent extrusion/looping of the region away
from its CT (Noordermeer et al., 2008). The limb bud enhancer
of the Shh gene is similarly required for extrusion of the gene
locus from its CT (Amano et al., 2009). These results suggest
that some enhancers mediate a change in nuclear localization
for genes in their vicinity and that this represents a step distinct
from transcriptional activation.
Second, in many metazoan cell types, active genes appear to
be localized in the interior of the nucleus, whereas silent genes
are found at the periphery. This correlation is not absolute. The
vicinity of the nuclear pore in yeast, for example, has actually
been associatedwith active genes (Taddei, 2007), and thus there
can be distinct compartments at the nuclear periphery. How-
ever, the nuclear periphery in general appears to exert a repres-
sive influence on genes that localize there. For example, artificial
tethering of reporter genes to the nuclear lamina or nuclear
periphery has been shown to result in downregulation of the
reporter and of neighboring genes, although not all genes are
affected (Andrulis et al., 1998; Finlan et al., 2008; Reddy et al.,
2008). A link between this pattern and enhancer function is again
provided by the b-globin locus. A study of b-globin locus posi-
tioning within the nucleus during erythroid differentiation demon-
strated that, at early maturational stages, the locus is found nearthe nuclear periphery (Ragoczy et al., 2006). As differentiation
proceeds and b-globin transcription is activated, the locus
moves more toward the interior of the nucleus. This process
requires the presence of the b-globin LCR, although here it is
not clear whether relocalization is a function of the LCR directly
or whether it represents an indirect consequence of LCR-depen-
dent b-globin gene activation. Separate studies of transgenes
under the control of an enhancer derived from the b-globin
LCR, however, indicated that, at ectopic integration sites, the
enhancer was required for localization of the transgene far
from regions of centromeric heterochromatin, and this was in
turn associated with a higher, stochastically determined proba-
bility of the gene being active at all (Francastel et al., 1999).
Third, the nucleus harbors a number of self-organized sub-
structures, proximity to which can affect gene expression (Ferrai
et al., 2010). In addition to the nuclear lamina, such substructures
include nucleoli, Cajal bodies, PML bodies, splicing speckles,
and other features that represent concentrations of factors that
can influence transcription—in the case of splicing speckles,
for example, of the splicingmachinery and other mRNA process-
ing factors. Such substructures can serve as the basis for coloc-
alization of genes that are otherwise located far apart on a linear
chromosome or even on different chromosomes. For example,
erythroid-specific genes have been found to be positioned
near common splicing speckles in erythroid cells (Brown et al.,
2008), whereas several muscle-specific genes have been shown
to localize to shared speckles in differentiated muscle cells
(Moen et al., 2004).
Finally, gene loci can colocalize in the nucleus on the basis of
shared associations with specific factors. Perhaps the most
notable of these is with RNA polymerase II itself. Visualization
using antibodies against RNApolymerase II or labeling of primary
mRNA transcripts have suggested that transcription is localized
to a limited number of RNA polymerase II ‘‘factories’’ (Iborra
et al., 1996;SutherlandandBickmore, 2009). Transcription facto-
ries have been proposed to underlie the observation that active
gene loci distributed across single chromosomesor even located
on separate chromosomes tend to colocalize in the nucleus
(Osborne et al., 2004; Simonis et al., 2006). In fact, some studies
have suggested that transcription factories occur in different vari-
eties, corresponding to transcription mediated by different
factors (Xu and Cook, 2008; Schoenfelder et al., 2010).
In addition to RNApolymerase II, other factors involved in tran-
scriptional regulation appear to organize into discrete foci in the
nucleus and can either directly or indirectly bring distal gene loci
into proximity with each other. These include, for example,
special AT-rich sequence binding protein 1 (SATB1), a protein
expressed in thymocytes and several other cell types that has
been implicated in anchoring disparate genomic loci via long-
range interactions (Cai et al., 2003; Cai et al., 2006). In thymo-
cytes SATB1 is observed in a ‘‘cage-like’’ distribution around,
but not coincident with, concentrations of centromeric hetero-
chromatin. SATB1, in turn, binds to promoter-distal regulatory
elements in multiple gene loci, and loss of the factor results in
disruptions of normal gene expression patterns and locus-wide
chromatin structure.
A special case of this category of interaction is presented by
CTCF, a zinc finger transcription factor that can have many rolesCell 144, February 4, 2011 ª2011 Elsevier Inc. 331
in gene regulation. Notably, CTCF binding to insulator elements
can block enhancer-mediated gene activation when such
elements are located between an enhancer and promoter (Phil-
lips and Corces, 2009). CTCF is capable of self-association
(Pant et al., 2004; Yusufzai et al., 2004) and has been implicated
in the formation of chromatin loops in vivo by 3C-based
approaches (Kurukuti et al., 2006; Splinter et al., 2006; Hou
et al., 2010). Interestingly, CTCF associates with cohesins,
protein complexes that physically connect sister chromatids
during mitosis and meiosis, and this association appears to be
necessary for enhancer-blocking activity (Rubio et al., 2008;
Wendt et al., 2008). A recent study of enhancers in embryonic
stem cells demonstrated that enhancers and promoters were
also associated with cohesin (Kagey et al., 2010), and the cohe-
sin-loading factor Nipbl (Nipped-B in Drosophila) was one of two
factors that emerged from a genetic screen in Drosophila for
factors involved in enhancer-promoter communication (Rollins
et al., 1999). Common association with cohesins provides a
potential mechanistic link between long-range associations
observed between CTCF-binding sites and between enhancers
and their cognate promoters.
Alternative Mechanisms and Remaining Issues
3C and its variants are inherently descriptive assays, and as with
most studies of nuclear organization, they do not provide
obvious ways to distinguish between correlation and causation.
Thus, whereas the spatial colocalization of active enhancer and
promoter regions revealed by 3C is suggestive of direct interac-
tions that mediate gene activation, it is formally just as likely that
it represents a consequence of a distinct activating mechanism.
RNA polymerase II transcription factories, for example, provide
an alternate mechanism by which enhancer-promoter colocali-
zation might take place (Figure 2A). RNA polymerase II is re-
cruited to many enhancers (Heintzman et al., 2007; Koch et al.,
2008; Kim et al., 2010). Although the function of this recruitment,
if any, is unknown, the likelihood that RNA polymerase II-bound
enhancers and promoters might colocalize by virtue of coinci-
dental association in such transcription factories has rarely
elicited much commentary. In some cases, it has been specu-
lated that part of the role of the enhancer is to transfer RNA poly-
merase II to the promoter directly (Zhu et al., 2007; Leach et al.,
2001), but this has not been demonstrated, and in the case of the
b-globin locus, RNA polymerase II still associates with the gene
promoter in the absence of the LCR (Sawado et al., 2003).
The function of RNA polymerase II recruitment to enhancers, if
it does not involve transfer to the promoter, is not clear, but
recent studies have shown that enhancers themselves are tran-
scribed. In one study, a population of 12,000 enhancers was
defined by the combination of H3K4Me1 and binding of the
transcription cofactor CBP (Kim et al., 2010). Roughly 25% of
the enhancers defined in this fashion were found to be associ-
ated with RNA polymerase II, and this subset was, in turn, tran-
scribed into RNA. The product RNAs, termed eRNAs, were
short, bidirectional, and not polyadenylated, and in at least
one case, eRNA transcription required the presence of the target
promoter. In another study, 70% of extragenic RNA polymerase
II binding in primary macrophages was found to map to
enhancers, as defined by the H3K4Me1 signature (De Santa
et al., 2010).332 Cell 144, February 4, 2011 ª2011 Elsevier Inc.Such findings complement earlier studies that have shown
transcription originating from specific enhancers, for example
at HS2 of the b-globin LCR (Kim et al., 2007b; Zhu et al., 2007).
In a few cases, nongenic transcription originating from
enhancers has been shown to be necessary for normal gene acti-
vation. For example, at transgenic human growth hormone loci in
mice, a large region located upstream of the growth hormone
gene is transcribed in an enhancer-dependent fashion (Ho
et al., 2006). Insertion of a transcriptional terminator in this region
partially eliminates this nongenic transcription pattern and, in
turn, results in a decrease in growth hormone gene expression.
Another study has suggested that some noncoding RNAs
(ncRNAs) act as enhancers on neighboring genes (Ørom et al.,
2010). The authors identified a set of several thousand unique,
long ncRNAs and then focused on a subset that exhibited differ-
ential expression during keratinocyte differentiation. RNAi-medi-
ated knockdown of several of these ncRNAs resulted in a
decrease in expression of neighboring genes. Further analysis
of one ncRNA, located near the gene for the transcription factor
Snai1, revealed that it behaved as a classical enhancer in tran-
sient reporter gene assays and furthermore that it was the RNA
itself that was required for the effect. The ncRNAs characterized
in this study appear to be distinct from eRNAs; the former, for
example, are polyadenylated, whereas the latter are not.
The significance of eRNA transcription is not known, and
the mechanism by which ncRNAs might mediate activation of
neighboring (but distal) genes is similarly unclear. Such studies,
however, reveal an unforeseen complexity to the roles of RNA
polymerase II association with enhancers and of the association
of enhancers with transcription factories and suggest functions
for noncoding RNA for which conventional models of enhancer-
mediated gene activation currently do not account (Figure 3C).
Several studies have provided evidence for a mechanism of
enhancer function distinct from, or perhaps complementary to,
the nuclear colocalization implied by 3C-based studies. Within
the b-globin locus, some chromatin-modifying enzymes—
notably, the histone H3 lysine 4 methyltransferase MLL2 and
the histone H3 lysine 9 methyltransferase G9a—have been
shown to be recruited by association with the enhancer-binding
factor NF-E2 and then to spread locus-wide (Demers et al., 2007;
Chaturvedi et al., 2009). In addition, a class of enhancer activity is
suggested by studies of enhancers within the endogenous
mouse b-globin locus and within a transgenic human growth
hormone locus in mice. In both cases, the active genes are
embedded within a larger ‘‘domain,’’ extending for 15–30 kb
and defined by high levels of histone hyperacetylation. Deletion
of binding sites for the transcription factor Pit-1 within the trans-
genic human growth hormone locus (Ho et al., 2002) or of an
evolutionarily conserved enhancer located between the embry-
onic b-globin genes (G. Fromm and M.B., unpublished data)
results in complete loss or significant decreases in expression,
respectively, coupled with complete loss of the hyperacetylated
domain. Thus, enhancers can also control chromatin modifica-
tions that are distributed continuously over large regions in a
manner analogous to silencers that control heterochromatic
domains (Figure 3B; see also below).
Another function for enhancers is emerging from studies of
epigenetic marks in pluripotent embryonic stem (ES) cells
Figure 3. Alternative Mechanisms of
Enhancer Function
(A) Placeholding. In ES cells, the enhancer (E,
orange bar) is occupied by ES cell-specific tran-
scription factors, but the gene promoter (P, blue
bar) is not active. Upon differentiation along the
lineage in which the gene is normally expressed,
the ES cell-specific factors are downregulated,
but new cell-specific factors occupy the enhancer
in their place and mediate gene activation (upper-
right). Upon differentiation into another lineage,
the ES cell-specific factors are not replaced, and
the locus is inactivated (lower-right).
(B) Spreading. The enhancer is bound by a factor
or factors that recruit chromatin-modifying or
other activities (light and dark blue ovals), which
then spread along the chromatin fiber bidirec-
tionally until they reach a promoter. Histones may
be modified throughout the region (nucleosomes
shaded blue), leading to the formation of a distinct
chromatin domain.
(C) Noncoding RNA. The enhancer is bound by
RNA polymerase II and transcribed. By as yet
undefined mechanisms, the noncoding RNA then
mediates transcriptional activation of a neigh-
boring but still distal gene promoter.(Figure 3A). In several cases, ‘‘pioneer’’ transcription factors have
been found to associatewithdistal enhancers inEScells, although
they do not mediate gene activation. These factors are then lost
upon ES cell differentiation. If differentiation proceeds along
a lineagewithin which the enhancer is normally active, the pioneer
factor is replaced with another factor that mediates enhancer-
dependent gene activation. If differentiation proceeds along
another lineage, loss of the pioneer factor results in inactivation
of the enhancer and thus the entire gene locus. For example, an
enhancer within the liver-specific Alb1 gene locus is bound by
the transcription factor FoxD3 in ES cells; binding of FoxD3
prevents DNA methylation at this enhancer. Upon differentiation
into endoderm, FoxD3 is replaced by FoxA1, the activating factor,
and the Alb1 gene is transcribed (Xu et al., 2009). Differentiation
into another lineage is accompanied by DNA methylation at the
enhancer. Similar models have been presented for the macro-
phage/dendritic cell gene IL12b, the thymocyte-specific Ptcra
gene (Xu et al., 2009), and for an enhancer within the pre-B cell-
specific l5/VpreB1 gene locus (Liber et al., 2010).
These examples suggest a general model in which develop-
mental and lineage maturation decisions to activate or to silence
a given gene locus are postponed until specific time points via
the binding of pioneer transcription factors at enhancer
elements. Factor binding to the enhancer thus acts as a ‘‘place-
holder’’ for a later step in gene regulation. Although this mecha-
nism for enhancer function does not involve direct activation of
gene promoters, it is no less necessary for the proper regulation
of transcription and represents an indirect method by which
enhancers can affect gene activation.
Thus, whereas most studies of enhancer function have
focused on models involving direct enhancer-promoter interac-
tions and the assays that can reveal them, other studies indicate
that regulation at a distance can involve indirect mechanisms as
well. Transcription of enhancers, noncoding RNAs, enhancer
placeholding, and spreading mechanisms are likely to be impor-
tant for the function of at least some enhancers, and observa-tions of such phenomena raise the larger possibility that simple
models of enhancer-promoter looping are not sufficient to
account for enhancer activity.
Enhancers, Disease, and Evolution
While initially discovered through the direct activation of gene
transcription, enhancers influence a variety of fundamental
cellular phenomena, such as stem cell multipotency and chro-
mosomal and nuclear organization. Enhancer function is also
emerging as an important component in human disease and
metazoan evolution. Assuming that an enhancer is marked by
a nucleosome-free region that can extend for 200–300 bp, esti-
mates of the abundance of enhancers suggest that they could
comprise as much as 10% of the human genome. For compar-
ison, the total extent of protein-coding sequences in the human
genome is estimated at 2%–3%. Mutations within protein-
coding sequences are well established as a basis for human
disease, with many thousands of known examples, so it is unsur-
prising to find that mutations within enhancers can similarly lead
to heritable disorders. For example, some instances of X-linked
deafness type 3 are associated with loss of an enhancer region
located 900 kb upstream of the POU3F4 gene (de Kok et al.,
1996). An enhancer located within the first intron of the RET
proto-oncogene occurs in a variant that confers a 20-fold
increased risk for Hirschsprung’s disease (Emison et al., 2005).
Numerous other examples have been presented, indicating
that noncoding distal regulatory sequences represent a target
for mutations that can lead to disease (Kleinjan and van Heynin-
gen, 2005; Visel et al., 2009b; Noonan and McCallion, 2010).
Thus far, however, the proportion of known mutations that
localizes to enhancer sequencesdoes not alignwith the apparent
complexity of the enhancer population in the genome. A very
small percentage of mutations documented in the Human Gene
Mutation Database map to noncoding DNA, and the majority of
these correspond to promoter-proximal regions (Noonan and
McCallion, 2010). In part, this may stem from the historicalCell 144, February 4, 2011 ª2011 Elsevier Inc. 333
difficulty in mapping and characterizing gene-distal enhancers
and thus reflect an artificial bias for protein-coding regions.
Another contributing factor, however, may be that enhancers
are not as sensitive to single base pair alterations as protein-
coding sequences. Though such changes have the potential to
fundamentally alter transcription factor association and render
an enhancer nonfunctional, they are more likely to alter binding
affinities or developmental patterns of association in ways that
can change function more subtly without eliminating it. While
a mutation in a protein-coding region will affect function in every
cell in which the protein is expressed, a mutation in an enhancer
may affect only part of the expression pattern. Enhancer muta-
tions are therefore a potentially powerful engine for intraspecies
variation and, insofar as such changes affect selectable traits, for
evolutionary divergence (Rebeiz et al., 2009; Visel et al., 2009b;
Levine, 2010; Noonan and McCallion, 2010).
Illustrations of the principle include freshwater stickleback fish
populations, which lack pelvic fins that are present in saltwater
stickleback populations and in ancestral fish. Freshwater stickle-
backs have lost an enhancer that regulates the gene for the
homeobox transcription factor Pitx1. In stickleback fish that
have pelvic fins, this enhancer specifically activates Pitx1 gene
expression in the pelvic fins during development (Chan et al.,
2010; Levine, 2010). Another study defined a series of mutations
in an enhancer for the ebony gene in Drosophila (Rebeiz et al.,
2009). Populations of Drosophila in Uganda exhibit a correlation
between their abdominal pigmentation and the elevation of their
primary habitat. Abdominal pigmentation is influenced by the
product of the ebony gene, in the absence of which the abdomen
exhibits a dark, melanic phenotype. An analysis of dark versus
light-colored lines resulted in the identification of a distal
enhancer for the ebony gene, mutations in which give rise to
phenotypic variation.
Several studies have systematically attempted to define
human-specific mutations in noncoding genomic DNA se-
quences that are otherwise highly conserved amongmammalian
species. Such analyses are able to define isolated sequences,
termed ‘‘human-accelerated conserved noncoding elements’’
(HACNSs) or ‘‘human-accelerated regions’’ (HARs), that in
some cases appear to be enhancers (Pollard et al., 2006; Prab-
hakar et al., 2006; Noonan, 2009). Notably, one element,
HACNS1/HAR2, consists of 81 bp, within which 16 human-
specific substitutions have accumulated during evolution.
When tested in reporter constructs in transgenic mice, the
human version acts as an enhancer to drive gene expression in
the developing anterior limb and a few other locations (Prabha-
kar et al., 2008). Versions of this element that lack the human-
specific substitutions fail to direct gene expression to the
developing limb. Although the biological significance of this
expression pattern, including the gene(s) influenced by
HACNS1/HAR2, is unknown, such behavior provides a concrete
demonstration that changes in enhancer function can alter
expression patterns to generate variation.
Action at a Distance in Single-Celled Organisms
Abundant evidence exists to assign a wide-ranging and crucial
role for enhancers in accomplishing complex patterns of gene
expression that underlie cell type specificity inmetazoans.More-334 Cell 144, February 4, 2011 ª2011 Elsevier Inc.over, such function has a significant impact on considerations of
evolution and disease in multicellular organisms. In prokaryotes
and unicellular eukaryotes, however, DNA sequences that
mediate gene regulation over large genomic distances represent
exceptions rather than the rule. Such exceptions, however, may
be informative when compared and contrasted to the activity of
metazoan enhancers.
In the budding yeast S. cerevisiae, for example, regulatory
sequences are usually limited to upstream activation sequences
(UASs) that are located within a few hundred base pairs of the
promoter. Relocation of a UAS at greater distances results in
loss of function (Dobi and Winston, 2007). Artificial model
systems in yeast, however, have shown that bridging of distal
sequences can be accomplished. Integration of expression
cassettes within yeast telomeres, which naturally fold and can
bring distal elements within close proximity of each other, or
use of the self-associating Drosophila GAGA factor to mediate
looping between two sequences have demonstrated that gene
activation can be accomplished by simple looping interactions
(de Bruin et al., 2001; Petrascheck et al., 2005).
In addition, regulatory elements that appear to act like
enhancers by activation at a distance and/or from positions
downstream of the promoter have been found at select gene
loci in S. cerevisiae. The most notable example in this regard is
the gene for the HO endonuclease, an enzyme involved in
mating-type switching that is expressed in a brief window during
late G1 phase of the cell cycle. The process of HO gene activa-
tion requires binding of the transcription factor Swi5 to two sites
located more than 1 kb upstream of the promoter (Figure 3A).
Swi5, in turn, is required for recruitment of chromatin remodeling
factors and results in histone acetylation across the entire region
between the binding sites and the promoter. Interestingly,
binding of Swi5 is a transient event, and HO gene activation
occurs well after Swi5 is no longer present, suggesting that these
distal regulatory elements initiate an activation mechanism that
is maintained by chromatin remodeling at the promoter in an
indirect fashion (Cosma et al., 1999; Krebs et al., 1999).
Studies in yeast also provide a cautionary note that may be
applied to enhancer studies in metazoans. For example, early
investigations of the S. cerevisiase rRNA genes identified an
apparent transcriptional enhancer located downstream of the
35S rRNA gene. In transgene constructs, this enhancer region
mediated 10- to 30-fold increases in 35S rRNA transcription
and was also selective, having no effect on the 5S rRNA gene
located between the enhancer region and the 35S rRNA
promoter (Neigeborn and Warner, 1990; Morrow et al., 1993).
The results suggested a simple model in which the enhancer in-
teracted with the 35S rRNA gene promoter by a looping mecha-
nism, with the intervening 5S gene isolated within the loop.
Subsequent studies, however, demonstrated that the enhancer
was unnecessary for endogenous 35S rRNA expression (Wai
et al., 2001) and instead functioned in ectopically integrated
reporter constructs to recruit RNA polymerase I, which is other-
wise primarily localized within the nucleolus. Such findings may
be instructive for any study in which the potential function of
a distal enhancer is investigated outside of its normal context.
Finally, yeast heterochromatin provides a well-established
model for action at a distance in single-celled eukaryotes.
Figure 4. Mechanisms of Distal Regulatory Element Function
in Yeast and Bacteria
(A) Mating-type silencing in S. cerevisiae (spreading). In this simplified repre-
sentation, a discrete silencer element is bound by several factors (ORC, Abf1p,
and Rap1p), which in turn recruit a complex of SIR proteins that includes
a histone deacetylase. Deacetylated nucleosomes (in pink) are, in turn,
recognized by the SIR complex, which can then deacetylate additional
nucleosomes, resulting in a progressive spread of histone deacetylation and
associated SIR complexes. Genes within the region are silenced.
(B) Enhancer-binding protein interactions with s54-dependent promoters in
bacteria (looping). An enhancer sequence is recognized by an enhancer-Notably, the simplest version of this model, exemplified by
silencing at the yeast mating-type gene loci, is entirely indirect:
silencer elements within the locus serve to nucleate a complex
of Sir proteins (Rusche et al., 2003). The complex includes the
histone deacetylase Sir2, which deacetylates the histone tails
of nearby nucleosomes. Other components of the complex
bindwith high affinity to deacetylated histone tails and then serve
to recruit more of the Sir2 deacetylase, resulting in a progressive
spreading of histone deacetylation and silencing factors along
the chromatin fiber (Figure 4A). In this way, DNA sequences
that in themselves do not encode information sufficient for silent
regulation are packaged in a repressive chromatin structure. It
has been shown that, once established, silencing is maintained
in yeast cells even after the silencer itself is excised by an
in vivo recombination strategy, although the silencer is still
required for re-establishment of the silent state after cell division
(Holmes and Broach, 1996).
Silent domains in yeast, however, can be established and
maintained discontinuously. For example, silent domains at
yeast telomeres or within the HMR locus can encompass artifi-
cially inserted active genes. Such behavior involves the activity
of ‘‘proto-silencer’’ elements located elsewhere in the domain
that have no activity by themselves but can augment the activity
of canonical silencers (Talbert and Henikoff, 2006). Recently, it
has been demonstrated that silencers within the HMR locus in
yeast colocalize, as determined by 3C (Valenzuela et al., 2008).
Thus far, however, it is not clear whether discontinuous silencing
requires such direct interactions or whether it occurs indirectly
by localization to nuclear subcompartments enriched in silencing
factors. Such issues directly parallel corresponding aspects of
enhancer function, as described above.
Studies of enhancer elements in bacteria have provided
elegant demonstrations of both the looping and tracking models
(reviewed by Xu and Hoover, 2001). A number of bacterial genes
regulated by the s54 holoenzyme are also controlled by factors
that bind to enhancer sequences that can be located up to 3 kb
upstream and 1.5 kb downstream of the promoter. These
enhancer binding proteins then interact directly with the s54
holoenzyme via DNA looping, and notably, in some cases, the
looping mechanism is facilitated by additional factors that bind
between the enhancer and promoter and bend DNA (Figure 4B).
In contrast, a distal enhancer that is required for activation of
phage T4 late genes functions by the loading of a ring-shaped
trimer of a factor termed gp45, followed by one-dimensional
diffusion of the trimeric protein along the DNA until it reaches
the promoter (Figure 4C).binding protein (EBP), and in turn, the promoter is recognized by a s54 holo-
enzyme that includes RNA polymerase. This closed complex is only activated
upon direct interaction between the EBP and s54 (bottom), which can be
facilitated by DNA bending mediated by integration host factor (IHF) binding
between the enhancer and promoter.
(C) Activation of phage T4 late genes (tracking). A sliding clamp, consisting of
a trimer of gp45 polypeptides, is loaded at a promoter-distal site by the gp44-
gp62 complex. The gp45 trimer then tracks or slides along the DNA until it
reaches the promoter, where it mediates gene activation. In this representa-
tion, RNA polymerase and additional factors (gp33 and gp55) are present at
the promoter in a closed complex prior to the arrival of gp45, but this is not
known; in other models, the polymerase can track with gp45, for example.
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In summary, studies in organisms that typically lack enhancer
activity indicate that distal sequences can affect gene expres-
sion by widely different mechanisms and imply that many
enhancers could have evolved independently. In addition, there
is no reason to exclude the possibility that a given enhancer
might work by a combination of mechanisms. Thus, such studies
argue against simple, unified models for enhancer function in
metazoans.
Conclusions
Enhancers were discovered nearly 30 years ago, and for most of
the intervening period, they existed in the experimental literature
largely as an odd feature of certain tissue-specific loci, with a
peculiar ability to activate transcription from promoters over
large genomic distances. Only recently have advances in tech-
nology and understanding provided a fuller delineation of the
wide role that distal enhancers play in gene regulation in meta-
zoans. Their function is not only likely to constitute a primary
basis for differential gene expression that underlies cell type
specificity, but also to have crucial functions in stem cell pluripo-
tency, human disease, andmetazoan evolution. Mechanistically,
enhancers lie at the nexus of transcription, nuclear organization,
chromatin structure, epigenetics, and noncoding RNA. In accor-
dance with such a complex spectrum of biological functions, it
seems unlikely that enhancers constitute a monolithic class of
regulatory element that works via a single, unified mechanism.
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